Company Overview and News

 
Zacks Value Investor Highlights: Lannett, Emerge Energy, Roadrunner, GameStop and Micron

2018-04-13 zacks
Chicago, IL – April 13, 2018 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
Upvote Downvote

 
Should You Buy Stocks with P/Es under 5?

2018-04-12 zacks
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio service, shares some of her top value investing tips and stock picks.
Upvote Downvote

1
EMES / Emerge Energy Services LP 424B3 (Prospectus)

2018-04-06 sec.gov
Use these links to rapidly review the document TABLE OF CONTENTS
Upvote Downvote

 
Just The Numbers... Plus: Frac Sand Companies

2018-03-29 seekingalpha
Frac sand entities take several forms: as divisions of large oilfield service companies, as part of public industrial sand companies or limited partnerships, and as private companies.
Upvote Downvote

 
What Does The Abundance Of Recent Bearish News Mean For Sand Fracking Companies?

2018-03-27 seekingalpha
Unexpected FERC bear news took the MLP sector for a loop, but doesn't apply to sand fracking companies.
Upvote Downvote

 
EMES / Emerge Energy Services LP S-3

2018-03-20 sec.gov
Use these links to rapidly review the document TABLE OF CONTENTS
Upvote Downvote

 
Canadian National Railway Struggles to Make On-Time Deliveries - WSJ

2018-03-16 wsj
TORONTO—Service problems at Canadian National Railway Co. CNI -1.33% , caught off guard by an oil-sector rebound, are causing severe delays in deliveries of grain, fracking sand, crude and other goods from Wisconsin to the Canadian West Coast.
Upvote Downvote

1
SA Interview: Distressed Investing With Green Knight

2018-03-11 seekingalpha
How to find distressed opportunities, an example of an ideal event-driven trade and the appeal of bank debt vs. HY are topics discussed.
Upvote Downvote

 
CN Rail abruptly replaces CEO amid ‘poor operating performance’

2018-03-05 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
EMES / Emerge Energy Services LP 10-K (Annual Report)

2018-03-01 sec.gov
Document Table of Contents
Upvote Downvote

 
Emerge Energy Services: Economic Factors Indicate Deep Value

2018-03-01 seekingalpha
Now that we have all had some time to take in the earnings call for Emerge Energy Services (NYSE:EMES), I believe it is the perfect time to add some clarity to the 2017 annual performance, including Q4 as well as the future outlook described in the call. These are exciting times for this company, and I would even go as far as to say this is the best position the company has been in since the drastic oil decline that began in June of 2014.
Upvote Downvote

1
Hi-Crush: Ready For Liftoff

2018-02-27 seekingalpha
The Permian Basin is where the action is at, and where Hi-Crush has many of its competitive advantages.
Upvote Downvote

 
Emerge Energy Services LP (EMES) Full Year 2018 Guidance - Slideshow

2018-02-27 seekingalpha
The following slide deck was published by Emerge Energy Services LP in conjunction with this event.
Upvote Downvote

 
Emerge Energy Services' (EMES) CEO Rick Shearer on Q4 2017 Results - Earnings Call Transcript

2018-02-27 seekingalpha
Emerge Energy Services LP (NYSE:EMES) Q4 2017 Results Earnings Conference Call February 26, 2018 4:00 PM ET
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 29102H108